13F-HR filed by Sessa Capital IM, L.P.
Sessa Capital IM, L.P. filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 43 holding rows worth $2,091,142,000.
- Accession
- 0001398344-22-009768
- Filer
- CIK 1595849
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 43 entries on the cover page, a total value of $2,091,142,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,091,145,000 with VALUE read as thousands by filing date, 13F file number 028-16593. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Tesla Motors, Inc | 88160R101 | COM | 319,200 | $343,970,000 | thousands by filing date | put |
| AT&T Inc | 00206R102 | COM | 11,186,667 | $264,341,000 | thousands by filing date | |
| CHEMOURS CO COM | 163851108 | Stock | 7,028,398 | $221,254,000 | thousands by filing date | |
| GARRETT MOTION INC | 366505204 | PFD CONV SER A | 16,592,384 | $137,219,000 | thousands by filing date | |
| EQUITABLE HLDGS INC COM | 29452E101 | Stock | 3,709,521 | $114,661,000 | thousands by filing date | |
| DISCOVERY INC | 25470F302 | COM SER C | 4,519,093 | $112,842,000 | thousands by filing date | |
| CORTEVA INC COM | 22052L104 | Stock | 1,749,092 | $100,538,000 | thousands by filing date | |
| INTERNATIONAL FLAVORS&FRAGRANC COM | 459506101 | Stock | 694,043 | $91,149,000 | thousands by filing date | |
| APARTMENT INVT & MGMT CO CL A | 03748R747 | REIT | 9,932,043 | $72,703,000 | thousands by filing date | |
| ORION PROPERTIES INC COM | 68629Y103 | REIT | 4,515,253 | $63,214,000 | thousands by filing date | |
| DT MIDSTREAM INC COMMON STOCK | 23345M107 | Stock | 936,548 | $50,817,000 | thousands by filing date | |
| GARRETT MOTION INC | 366505105 | COM | 6,912,204 | $49,699,000 | thousands by filing date | |
| FLEX LTD ORD | Y2573F102 | Stock | 2,500,000 | $46,375,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 6,000,000 | $43,920,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 80,500 | $41,053,000 | thousands by filing date | put |
| JACKSON FINANCIAL INC COM CL A | 46817M107 | Stock | 903,188 | $39,948,000 | thousands by filing date | |
| COINBASE GLOBAL INC COM CL A | 19260Q107 | Stock | 200,000 | $37,972,000 | thousands by filing date | put |
| DISCOVERY INC | 25470F104 | COM SER A | 1,308,999 | $32,620,000 | thousands by filing date | |
| PRIMO WATER CORPORATION | 74167P108 | COM | 1,982,040 | $28,244,000 | thousands by filing date | |
| VAREX IMAGING CORP | 92214X106 | COMMON STOCK | 1,136,566 | $24,197,000 | thousands by filing date | |
| AT&T Inc | 00206R102 | COM | 1,000,000 | $23,630,000 | thousands by filing date | call |
| NXP SEMICONDUCTORS N V COM | N6596X109 | Stock | 112,053 | $20,739,000 | thousands by filing date | |
| DISH NETWORK CORPORATION | 25470M109 | CL A | 408,399 | $12,926,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422LAA5 | NOTE 5.000% 7/1 | 9,975,000 | $11,690,000 | thousands by filing date | principal |
| GORES GUGGENHEIM INC | 38286Q107 | CLASS A COM | 1,000,000 | $11,370,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 301,200 | $9,015,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 149,000 | $7,571,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 212,000 | $7,221,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 58,500 | $6,866,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 187,000 | $6,839,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 108,000 | $6,779,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 257,000 | $6,086,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 249,000 | $6,031,000 | thousands by filing date | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 341,302 | $5,823,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 181,000 | $5,712,000 | thousands by filing date | |
| FAR PEAK ACQUISITION CORP | G3312L103 | SHS CL A | 516,536 | $5,134,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 82,000 | $5,086,000 | thousands by filing date | |
| CONCORD ACQUISITION CORP | 206071102 | COM CL A | 500,000 | $4,975,000 | thousands by filing date | |
| VELOCITY ACQUISITION CORP | 92259E104 | COM CL A | 400,650 | $3,906,000 | thousands by filing date | |
| ALTUS POWER INC | 02217A102 | COM CL A | 357,849 | $2,659,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 244,864 | $2,157,000 | thousands by filing date | |
| RXSIGHT INC | 78349D107 | COM | 164,282 | $2,034,000 | thousands by filing date | |
| BRAEMAR HOTELS RESORTS INC | 10482B101 | REIT | 25,951 | $160,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001398344-22-009768 | this filing | 2022-05-16 | acceptance time not in the bulk data set |